CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation
Authors:
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral VectorsThe Journal of Immunology, 2002
- Accumulation of Immature Langerhans Cells in Human Lymph Nodes Draining Chronically Inflamed SkinJournal of Experimental Medicine, 2002
- Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cellsGene Therapy, 2002
- Exploiting dendritic cells to improve vaccine efficacyJournal of Clinical Investigation, 2002
- Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in VivoJournal of Experimental Medicine, 2001
- Targeting of Adenovirus to Endothelial Cells by a Bispecific Single-Chain Diabody Directed against the Adenovirus Fiber Knob Domain and Human Endoglin (CD105)Molecular Therapy, 2001
- Targeting of adenoviral vectors through a bispecific single-chain antibodyCancer Gene Therapy, 2000
- Review: Gene-Modified Dendritic Cells for Use in Tumor VaccinesHuman Gene Therapy, 2000
- Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacityGene Therapy, 2000
- The ‘adenobody’ approach to viral targeting: specific and enhanced adenoviral gene deliveryGene Therapy, 1997